HER2-positive breast cancer is driven by HER2 protein overexpression, historically linked to poor outcomes but now improved by targeted therapies. Treatment varies by stage, involving surgery, ...

Don't Do Me Like That: Promoting Respectful Language in Oncology Research As state laws and national guidelines proliferate, there is mounting evidence that opioid restrictions reduce opioid access ...

The SHARON trial combines chemotherapy, vitamins, and stem cells to treat advanced pancreatic cancer with BRCA or PALB2 mutations, showing promising early results. This precision medicine approach ...

Baylor University researchers have developed a novel approach to fight colorectal cancer, using modified bacteria as a courier to deliver potent cancer-killing proteins into tumor cells. Michael S.

Researchers have identified a new molecular target for treating pancreatic cancer. Scientists focused on transcription-replication conflicts (TRCs), which occur when the mechanisms responsible for ...

When it comes to exploring alternative cancer treatments, Mexico has emerged as a leading destination, offering innovative therapies, compassionate care, and a holistic approach. Renowned centers like ...

Treating pancreatic cancer remains one of oncology’s greatest challenges. The disease is often diagnosed at an advanced stage, progresses rapidly, and responds poorly to existing treatments.

MIT engineers have developed a new way to amplify the T-cell response to mRNA vaccines—an advance that could lead to much more powerful cancer vaccines and stronger protection against infectious ...

University of Houston assistant professor of Chemical and Biomolecular Engineering, Akash Gupta, is first on a paper exloring development of a new mRNA-based strategy that dramatically amplifies the T ...